Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bon Health vs NuviaRx

Bon Health
Graded #113

Lower grade

vs+3.799999999999997
NuviaRx
Graded #69

Higher grade

The verdict

NuviaRx takes it — 73.5/100 to 69.7/100.

NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuviaRx +12
75
87
Dose & formulationNuviaRx +8
64
72
Clinical oversightBon Health +3
85
82
Labs & monitoringBon Health +2
55
53
FulfillmentEven
72
72
Contract termsNuviaRx +2
53
55
Bon Health · left barNuviaRx · right bar

The numbers

MetricBon HealthNuviaRx
WeighScore69.7/10073.5/100
GradeCC
Scorecard rank#113#69
Semaglutide$120/mo (12-month plan, compounded)$140/mo (all doses, compounded)
Tirzepatide$170/mo (12-month plan, compounded)$170/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Bon Health

Graded #113 · C

Strengths

  • Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
  • Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
  • 24/7 physician support included free with your order; 1-3 day rapid dispatch
  • Licensed in all 50 states; uses 503A & 503B compounding pharmacies; brand-name Wegovy/Ozempic/Zepbound/Mounjaro also offered

Where it loses points

  • The advertised rates need a full year paid up front; billed monthly, semaglutide is $230 and the annual figure nearly doubles
  • The brand-name pages are marketing, not products — every Wegovy, Ozempic, Zepbound and Mounjaro CTA reads 'Coming Soon' and points back to the compounded version
  • Coverage is not published: a badge claims all 50 states while the weight-loss page says availability varies by state
  • The terms page returns a 404, so the refund mechanics behind the prepaid 3-, 6- and 12-month tiers cannot be read
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
NuviaRx

Graded #69 · C

Strengths

  • Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
  • Free delivery included; clinical evaluation and prescription bundled (if eligible)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
  • Named operating entity (NuviaRx Health Inc.) with a US address and phone support

Where it loses points

  • Compounding pharmacy partner not named ('partner pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Lowest pricing is 'as low as' — likely requires a longer prepaid plan
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard